Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bauersachs

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
VASA. Zeitschrift Fur Gefasskrankheiten|October 18, 2019
Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societiesRupert Bauersachs, Florian Langer, Christoph Kalka, et al.
Thrombosis Research|November 12, 2022
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practiceFlorian Langer, Horst E Gerlach, Alexandra Schimke, et al.
Haematologica|August 12, 2021
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trialCecilia Becattini, Rupert Bauersachs, Giorgio Maraziti, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 13, 2023
Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT StudyEberhard Rabe, Ulrich Hoffmann, Alexandra Schimke, et al.
BMC Cancer|July 28, 2011
Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFYSylvia Haas, Sebastian M Schellong, Ulrich Tebbe, et al.
JAMA|January 15, 2020
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.
Thrombosis and Haemostasis|March 9, 2012
Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patientsThomas Wilke, Antje Groth, Sabrina Mueller, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2018
The impact of co-morbidity on the disease burden of VTESonja Kroep, Ling-Hsiang Chuang, Alexander Cohen, et al.
Thrombosis Research|September 11, 2018
Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to workStefan N Willich, Ling-Hsiang Chuang, Ben van Hout, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2025
Triangulating data to define patient pathways, diagnostic and treatment patterns, and outcomes in cancer patients with deep vein thrombosis in Germany: a mixed-methods real-world data studyVanessa Colonna, Rupert Bauersachs, Roman Gerlach, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
VASA. Zeitschrift Fur Gefasskrankheiten|October 18, 2019
Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societiesRupert Bauersachs, Florian Langer, Christoph Kalka, et al.
Thrombosis Research|November 12, 2022
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practiceFlorian Langer, Horst E Gerlach, Alexandra Schimke, et al.
Haematologica|August 12, 2021
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trialCecilia Becattini, Rupert Bauersachs, Giorgio Maraziti, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 13, 2023
Determinants of Late Venous Thromboembolic Events After Acute Isolated Superficial Vein Thrombosis in Daily Practice: 12 Month Results of the INSIGHTS-SVT StudyEberhard Rabe, Ulrich Hoffmann, Alexandra Schimke, et al.
BMC Cancer|July 28, 2011
Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFYSylvia Haas, Sebastian M Schellong, Ulrich Tebbe, et al.
JAMA|January 15, 2020
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical TrialJeffrey I Weitz, Rupert Bauersachs, Bastian Becker, et al.
Thrombosis and Haemostasis|March 9, 2012
Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patientsThomas Wilke, Antje Groth, Sabrina Mueller, et al.
Journal of Thrombosis and Thrombolysis|September 16, 2018
The impact of co-morbidity on the disease burden of VTESonja Kroep, Ling-Hsiang Chuang, Alexander Cohen, et al.
Thrombosis Research|September 11, 2018
Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to workStefan N Willich, Ling-Hsiang Chuang, Ben van Hout, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 14, 2025
Triangulating data to define patient pathways, diagnostic and treatment patterns, and outcomes in cancer patients with deep vein thrombosis in Germany: a mixed-methods real-world data studyVanessa Colonna, Rupert Bauersachs, Roman Gerlach, et al.
Pageof 14